FDA approves new drug for severe drooling
On July 28, the U.S. Food and Drug Administration (FDA) approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
